Sun Pharmaceutical Industries Inc.
Sun Pharmaceutical Industries Inc., commonly referred to as Sun Pharma, is a leading global pharmaceutical company headquartered in the United States. Founded in 1993, Sun Pharma has established a strong presence in various operational regions, including North America, Europe, and Asia, focusing on the development and manufacturing of a diverse range of pharmaceutical products. Specialising in generic and specialty medications, Sun Pharma is renowned for its innovative formulations and high-quality standards. The company’s core offerings include treatments in areas such as psychiatry, neurology, cardiology, and dermatology, setting it apart with a commitment to research and development. With a robust market position, Sun Pharma has achieved significant milestones, including numerous product approvals and a growing portfolio of over 200 generic products. Its dedication to improving patient outcomes and expanding access to essential medications underscores its reputation as a trusted leader in the pharmaceutical industry.
DitchCarbon Score
How does Sun Pharmaceutical Industries Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sun Pharmaceutical Industries Inc.'s score of 27 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sun Pharmaceutical Industries Inc.'s reported carbon emissions
Sun Pharmaceutical Industries Inc., headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate commitments, often setting ambitious targets to reduce their carbon footprint across Scope 1, 2, and 3 emissions. However, without specific data or commitments from Sun Pharmaceutical, it is challenging to assess their current standing or future goals in relation to carbon emissions and climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sun Pharmaceutical Industries Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
